Phase II Trial of Cabazitaxel in Metastatic or Inoperable Locally Advanced Dedifferentiated Liposarcoma
Phase of Trial: Phase II
Latest Information Update: 02 May 2017
At a glance
- Drugs Cabazitaxel (Primary) ; Ifosfamide; Mesna
- Indications Liposarcoma
- Focus Therapeutic Use
- 27 Apr 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2019.
- 27 Apr 2017 Status changed from suspended to recruiting.
- 07 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Feb 2017 as reported by ClinicalTrials.gov.